In ₹ Crore except Per Share Latest Annual	GUJTHEM FY26	RPGLIFE FY26	GUFICBIO FY26	ORCHPHARMA FY26	Peer Average
Valuation — at last close
P/E	83.07×	157.30×	◆ 66.21×	521.08×	248.20× -67%
P/B	13.46×	7.77×	6.39×	◆ 3.31×	5.82× +131%
EV/EBITDA	53.33×	30.24×	◆ 30.12×	160.78×	73.71× -28%
Market Cap	₹3,874 Cr	₹4,703 Cr	₹4,249 Cr	₹5,180 Cr	₹4,711 Cr -18%
Growth
Revenue CAGR 3Y	—	—	—	22.79%	22.79%
Revenue CAGR 5Y	—	—	—	22.33%	22.33%
Net Income CAGR 3Y	—	—	—	-40.09%	-40.09%
Revenue YoY (latest Q)	22.07%	—	16.58%	◆ 75.89%	46.23% -52%
Net Income YoY (latest Q)	22.12%	—	◆ 70.71%	-78.38%	-3.84% +677%
Profitability
EBITDA Margin	◆ 45.55%	20.79%	16.03%	2.72%	13.18% +246%
Net Income Margin	◆ 28.15%	16.28%	6.80%	0.81%	7.96% +253%
Return on Common Equity	17.41%	◆ 20.28%	10.14%	0.70%	10.37% +68%
Return on Capital Employed	17.76%	◆ 21.46%	15.00%	-0.61%	11.95% +49%
Return on Assets	11.60%	◆ 15.88%	5.11%	0.50%	7.16% +62%
Credit & Quality
Total Debt/Equity	0.56×	◆ 0.03×	0.58×	0.19×	0.27× +110%
Interest Coverage	21.23×	◆ 141.13×	3.29×	-1.08×	47.78× -56%
Scale — latest FY
Revenue / Total Income	₹166 Cr	₹708 Cr	₹944 Cr	₹1,233 Cr	₹961 Cr -83%
Net Income	₹46.7 Cr	₹115 Cr	₹64.2 Cr	₹10 Cr	₹63.1 Cr -26%
Total Assets	₹503 Cr	₹793 Cr	₹1,342 Cr	₹2,258 Cr	₹1,465 Cr -66%
EPS	₹4.28	₹18.08	₹6.4	₹1.66	₹8.71 -51%
Book Value per Share	₹26.41	₹366.07	₹66.31	₹261.22	₹231.2 -89%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.